Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Dickinson

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 18, 2005
Simultaneous determination of HIV protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir in human plasma by high-performance liquid chromatography-tandem mass spectrometryLaura Dickinson, Lesley Robinson, John Tjia, et al.
Frontiers in Pharmacology|March 29, 2019
The Utility of Efavirenz-based Prophylaxis Against HIV Infection. A Systems Pharmacological AnalysisSulav Duwal, Daniel Seeler, Laura Dickinson, et al.
The Journal of Antimicrobial Chemotherapy|December 30, 2015
Simulation of the impact of rifampicin on once-daily darunavir/ritonavir pharmacokinetics and dose adjustment strategies: a population pharmacokinetic approachLaura Dickinson, Alan Winston, Marta Boffito, et al.
Journal of the International AIDS Society|November 14, 2014
Simulation of the impact of rifampicin on darunavir/ritonavir PK and dose adjustment strategies in HIV-infected patients: a population PK approachLaura Dickinson, Alan Winston, Marta Boffito, et al.
Journal of American College Health : J of ACH|January 7, 2017
Naloxone administration for suspected opioid overdose: An expanded scope of practice by a basic life support collegiate-based emergency medical services agencyRyan M Jeffery, Laura Dickinson, Nicholas D Ng, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 27, 2012
Simultaneous population pharmacokinetic modelling of atazanavir and ritonavir in HIV-infected adults and assessment of different dose reduction strategiesAlessandro Schipani, Laura Dickinson, Marta Boffito, et al.
Pharmacogenomics|February 16, 2019
Impact of pharmacogenetics and pregnancy on tenofovir and emtricitabine pharmacokineticsJoshua Gini, Adeniyi Olagunju, Laura Dickinson, et al.
The Journal of Antimicrobial Chemotherapy|December 12, 2025
A model-based comparison of dose reduction strategies for fixed-dose dolutegravir-containing regimensLaura Dickinson, Laura Else, Willem D F Venter, et al.
The Journal of Antimicrobial Chemotherapy|May 10, 2008
Pharmacokinetic analysis to assess forgiveness of boosted saquinavir regimens for missed or late dosingLaura Dickinson, Marta Boffito, Saye H Khoo, et al.
The Journal of Antimicrobial Chemotherapy|March 31, 2009
Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteersLaura Dickinson, Marta Boffito, David Back, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 18, 2005
Simultaneous determination of HIV protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir in human plasma by high-performance liquid chromatography-tandem mass spectrometryLaura Dickinson, Lesley Robinson, John Tjia, et al.
Frontiers in Pharmacology|March 29, 2019
The Utility of Efavirenz-based Prophylaxis Against HIV Infection. A Systems Pharmacological AnalysisSulav Duwal, Daniel Seeler, Laura Dickinson, et al.
The Journal of Antimicrobial Chemotherapy|December 30, 2015
Simulation of the impact of rifampicin on once-daily darunavir/ritonavir pharmacokinetics and dose adjustment strategies: a population pharmacokinetic approachLaura Dickinson, Alan Winston, Marta Boffito, et al.
Journal of the International AIDS Society|November 14, 2014
Simulation of the impact of rifampicin on darunavir/ritonavir PK and dose adjustment strategies in HIV-infected patients: a population PK approachLaura Dickinson, Alan Winston, Marta Boffito, et al.
Journal of American College Health : J of ACH|January 7, 2017
Naloxone administration for suspected opioid overdose: An expanded scope of practice by a basic life support collegiate-based emergency medical services agencyRyan M Jeffery, Laura Dickinson, Nicholas D Ng, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 27, 2012
Simultaneous population pharmacokinetic modelling of atazanavir and ritonavir in HIV-infected adults and assessment of different dose reduction strategiesAlessandro Schipani, Laura Dickinson, Marta Boffito, et al.
Pharmacogenomics|February 16, 2019
Impact of pharmacogenetics and pregnancy on tenofovir and emtricitabine pharmacokineticsJoshua Gini, Adeniyi Olagunju, Laura Dickinson, et al.
The Journal of Antimicrobial Chemotherapy|December 12, 2025
A model-based comparison of dose reduction strategies for fixed-dose dolutegravir-containing regimensLaura Dickinson, Laura Else, Willem D F Venter, et al.
The Journal of Antimicrobial Chemotherapy|May 10, 2008
Pharmacokinetic analysis to assess forgiveness of boosted saquinavir regimens for missed or late dosingLaura Dickinson, Marta Boffito, Saye H Khoo, et al.
The Journal of Antimicrobial Chemotherapy|March 31, 2009
Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteersLaura Dickinson, Marta Boffito, David Back, et al.
Pageof 6